New dust testing methodology better protects workers from lung diseases

On­col­o­gy and res­pi­ra­to­ry drug de­vel­op­er in­voX Phar­ma is fine-tun­ing its pipeline and ex­pects to cut about one-third of its em­ploy­ees, the com­pa­ny con­firmed to …

The FDA last week sent a warn­ing let­ter to Chi­na-based Sichuan Dee­bio Phar­ma­ceu­ti­cal af­ter a Sep­tem­ber in­spec­tion led to da­ta in­tegri­ty and oth­er qual­i­ty con­trol